Compare Eli Lilly And Co (LLY) vs Oklo Inc (OKLO) Price & Performance

Eli Lilly And CoTrade

Oklo IncTrade

Price performance (Past 24H)

Key statistics

Eli Lilly And Co vs Oklo Inc — how do they compare? Eli Lilly And Co trades at $1,173 (market cap $1.02T), while Oklo Inc trades at $46.9 (market cap $7.22B). The key difference: Eli Lilly And Co is far larger — about 141.3× Oklo Inc's market cap, and Eli Lilly And Co pays a 0.6% dividend while Oklo Inc pays none. Which is the better fit depends on your goals.

	LLY	OKLO
Market Cap	$1.02T	$7.22B
Sector	Health	Technology
52-Week High	$1.24K	$174.14
52-Week Low	$625.65	$41.11
Enterprise Value	$1.06T	$5.02B
Dividend Yield	0.6%	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LLY

Over 180 companies develop 200+ PD-1/PD-L1 inhibitors, reshaping cancer treatment landscape.Delveinsight · 6 hours agoBullish Novo Nordisk sues Eli Lilly over misleading GLP-1 drug ads claiming superior weight-loss results.Proactive Investors · 12 hours agoBearish Novo Nordisk sues Eli Lilly over misleading ads on obesity and diabetes drug efficacy.CNBC · 16 hours agoBearish View details →

OKLO

US DOE formalizes Nuclear Fuel Cycle Consortium to boost domestic nuclear fuel resilience.ETF Trends · 1 day agoBullish View details →

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

About Oklo Inc

Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.